'Off-label' use of prescription drugs: legal, clinical and policy considerations.
Cohen
P J
PJ
D000293:Adolescent; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D017277:Drug Approval; D004363:Drug Utilization / Q000331:legislation & jurisprudence; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D020910:Ketorolac; D014046:Tolmetin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D018712:Analgesics, Non-Narcotic; D014046:Tolmetin; D020910:Ketorolac